Stock Price Quote

SURYA PHARMACEUTICAL LTD.

NSE : NABSE : 532516ISIN CODE : INE249G01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.160 (0 %)
PREV CLOSE ( ) 0.16
OPEN PRICE ( ) 0.16
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.16 (749508)
VOLUME 234695
TODAY'S LOW / HIGH ( )0.16 0.16
52 WK LOW / HIGH ( ) 0.160.16
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 25-03 1992
Management Info
Rajiv Goyal - Chairman Rajiv Goyal - Managing Director
Registered Office

Address 1596 ,1st Floor,Bhagirath Palace,
New Delhi,
New Delhi-110001

Phone

Email NA

Website www.suryapharma.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

12Aug Surya Pharmaceutical informs about fin
Surya Pharmaceutical has informed about the Financial Results & a co..
04Feb Surya Pharmaceutical informs about out
Surya Pharmaceutical has informed that the Board of Directors of the Com..
25Nov Surya Pharmaceutical informs about AGM
Surya Pharmaceutical has informed regarding 'Reschedulement / Adjournmen..
03Nov Surya Pharmaceutical informs about Fin
Surya Pharmaceutical has informed about the Standalone Financial Results..
03Nov Surya Pharmaceutical Fixes Book Closur
Surya Pharmaceutical has informed that the Register of Members & Sha..

Financials

in Millions
QTR Dec 14 ANNUAL 14
Net Profit-171.76-7267.71
Gross Profit -171.76 -11706.24
Operating Profit -171.72-8532.1
Net Sales 0126.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4532.55 (3.45%)
M.Cap ( in Cr)20494.98
Abbott India (BSE)
peergroup  28720.00 (0.28%)
M.Cap ( in Cr)60810.19
Bajaj Healthcare (BSE)
peergroup  367.65 (14.75%)
M.Cap ( in Cr)1013.69
Jenburkt Pharma (BSE)
peergroup  789.60 (3.55%)
M.Cap ( in Cr)346.44
Caplin Point Lab (BSE)
peergroup  1448.90 (1.65%)
M.Cap ( in Cr)10972.44

Shareholding Pattern

NON-INSTITUTION 99.01%
PROMOTERS 0.96%
FI/BANKS/INSURANCE 0.02%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Surya Pharmaceutical Ltd.

Surya Pharmaceutical Ltd. was incorporated in the year 1992. Its today's share price is 0.16. Its current market capitalisation stands at Rs 3.24 Cr. In the latest quarter, company has reported Gross Sales of Rs. 646.22 Cr and Total Income of Rs.611.78 Cr. The company's management includes Jasvinder Singh, Alka Goyal, Rajiv Goyal, Rajiv Goyal.

It is listed on the BSE with a BSE Code of 532516 , NSE with an NSE Symbol of SURYAPHARM and ISIN of INE249G01020. It's Registered office is at 1596 ,1st Floor,Bhagirath PalaceNew Delhi-110001, New Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AAD & Associates, MSN & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.